loadpatents
Patent applications and USPTO patent grants for Skotnicki; Jerauld S..The latest application filed is for "beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase".
Patent | Date |
---|---|
Rapamycin hydroxyesters Grant RE44,768 - Skotnicki , et al. February 18, 2 | 2014-02-18 |
Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders Grant 7,795,252 - Graziani , et al. September 14, 2 | 2010-09-14 |
Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase Grant 7,595,327 - Levin , et al. September 29, 2 | 2009-09-29 |
Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase App 20060211730 - Levin; Jeremy I. ;   et al. | 2006-09-21 |
Carbamates of rapamycin Grant 5,567,709 - Skotnicki , et al. October 22, 1 | 1996-10-22 |
Carbamates of rapamycin Grant 5,559,112 - Skotnicki , et al. September 24, 1 | 1996-09-24 |
Rapamycin amidino carbamates Grant 5,541,191 - Skotnicki , et al. July 30, 1 | 1996-07-30 |
Carbamates of rapamycin Grant 5,532,355 - Skotnicki , et al. July 2, 1 | 1996-07-02 |
Rapamycin amidino carbamates Grant 5,508,286 - Skotnicki , et al. April 16, 1 | 1996-04-16 |
Rapamycin amidino carbamates Grant 5,463,048 - Skotnicki , et al. October 31, 1 | 1995-10-31 |
Carbamates of rapamycin Grant 5,434,260 - Skotnicki , et al. July 18, 1 | 1995-07-18 |
Phosphorylcarbamates of rapamycin and oxime derivatives thereof Grant 5,391,730 - Skotnicki , et al. February 21, 1 | 1995-02-21 |
Rapamycin hydroxyesters Grant 5,362,718 - Skotnicki , et al. November 8, 1 | 1994-11-08 |
Substituted tetrahydropyrido[3',4':4,5]-pyrrolo[3,2-c]quinolines Grant 5,281,608 - Skotnicki , et al. January 25, 1 | 1994-01-25 |
Macrocyclic immunomodulators Grant 5,252,579 - Skotnicki , et al. October 12, 1 | 1993-10-12 |
1-Substituted-4-pyrrolidinopiperidines as inhibitors of interleukin 1 Grant 4,902,800 - Skotnicki February 20, 1 | 1990-02-20 |
2-amino-3-cyano-bicyclic pyridines/pyrazines as inhibitors of interleukin 1 Grant 4,902,685 - Skotnicki February 20, 1 | 1990-02-20 |
Substituted 1,2-dihydro-4h-3,1-benzoxazin-4-one derivatives inhibitors of interleukin 1 Grant 4,894,374 - Skotnicki , et al. January 16, 1 | 1990-01-16 |
Cyclohexylquinolines as inhibitors of interleukin 1 Grant 4,851,536 - Skotnicki , et al. July 25, 1 | 1989-07-25 |
10-Substituted benzo[b][1,6]naphthyridines as inhibitors of interleukin 1 Grant 4,816,464 - Gilman , et al. March 28, 1 | 1989-03-28 |
2-Arylbenzo(b)(1,6)naphthyridines as inhibitors of interleukin 1 Grant 4,808,612 - Skotnicki , et al. February 28, 1 | 1989-02-28 |
C-3'thioiminosulfonyl cephalosporin analogs Grant 4,728,734 - Skotnicki , et al. March 1, 1 | 1988-03-01 |
C-3' acylaminooxy-7-[(2-aminothiazol-4-yl)-.alpha.-(substituted-oximino)acety l]cephalosporin derivatives Grant 4,692,517 - Skotnicki , et al. September 8, 1 | 1987-09-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.